David W. Parke - Concepedia

Author

David W. Parke

Also Known As

D W ParkE, D Wilkin Parke, D. W. Parke, D. W. Parke II, D. Wilkin Parke, D. Wilkin Parke III, DAVID WILKIN Parke, David Parke, David W Parke, David W. Parke

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

American Academy of Ophthalmology Baylor College of Medicine Stanford University Wills Eye Hospital Oregon Health & Science University

About

David W. Parke is an author at American Academy of Ophthalmology specializing in ophthalmology, medicine, and surgery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	828
2	Public Health	2	2	37
3	Biostatistics	2	2	221
4	Epidemiology	1	1	20
5	Health Policy	1	1	17

David W. Parke

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Estimated number of ophthalmologists worldwide (International Council of Ophthalmology update): will we meet the needs? Serge Resnikoff, Van Charles Lansingh, Lindsey Washburn, British Journal of Ophthalmology	2019	354
The 2016 American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) Database Michael F. Chiang, Alfred Sommer, William L. Rich, Ophthalmology Intelligent ResearchOphthalmologyDatabasesBiostatisticsOphthalmology Iris® Registry	2018	195
Endogenous Endophthalmitis Among Patients with Candidemia David W. Parke, Dan B. Jones, Layne O. Gentry Ophthalmology Ocular DiseaseOphthalmologyEndogenous EndophthalmitisOcular PathologyInfection Control	1982	167
Endophthalmitis after Cataract Surgery in the United States Suzann Pershing, Flora Lum, Stephen I‐Hong Hsu, Ophthalmology Ophthalmic SurgeryOphthalmologyMedicineSurgeryOcular Pathology	2019	159
The Endophthalmitis Vitrectomy Study Mark W. Johnson, Bernard H. Doft, S. F. Kelsey, Ophthalmology Ophthalmic SurgeryVitreous BodyOphthalmologyExperimental OphthalmologyEndophthalmitis Vitrectomy Study	1997	157
Real-World Vision in Age-Related Macular Degeneration Patients Treated with Single Anti–VEGF Drug Type for 1 Year in the IRIS Registry Prethy Rao, Flora Lum, Kevin M. Wood, Ophthalmology Ocular DiseaseOphthalmologyReal-world VisionAge-related DiseasesIris Registry	2017	137
Endophthalmitis after Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors Kunyong Xu, Eric K. Chin, Steven R. Bennett, Ophthalmology Ocular DiseaseVitreous BodyOphthalmologyIntravitreal InjectionVascular Biology	2018	81
The Prevalence of Myopic Choroidal Neovascularization in the United States Jeffrey R. Willis, Susan Vitale, Lawrence S. Morse, Ophthalmology Ocular DiseaseOphthalmologyMedicineSurgeryGlaucoma	2016	52
Molecular Epidemiology of <i>Staphylococcus aureus</i> and <i>Enterococcus faecalis</i> in Endophthalmitis Mary C. Booth, Kenneth L. Hatter, Darlene Miller, Infection and Immunity	1998	33
Treatment Patterns for Myopic Choroidal Neovascularization in the United States Jeffrey R. Willis, Lawrence S. Morse, Susan Vitale, Ophthalmology Ocular DiseaseOphthalmologySurgeryOcular PathologyMedicine	2017	28

Page 1